News & Events

Towards the end of Biju Parekkadan’s tenure in HST’s Medical Engineering and Medical Physics (MEMP) PhD program, he received a wake-up call. He had traveled to India to observe medical practices and the healthcare system as a whole. During the visit, he presented his latest research about using cell therapy to reverse acute liver injury.

A local doctor asked, “When can I use this?” Parekkadan had no answer. “I realized there was more I could do to advance this technology. I was leaving a lot on the table.”

Meet Nina Menezes. Currently the Associate Director of Healthcare Strategy at Becton Dickinson (BD)—a global medical technology company that seeks to advance healthcare by improving medical discovery, diagnostics, and delivery of care—she admits that pursuing a medical career was never her dream. But with strong influences in her family and her own thoughtful consideration of the viability of such a career, she entered university intending to study medicine.

Tim Padera works to fight cancer and disease by focusing his research on a far-reaching system of the body—the lymphatic system. As part of the Edwin L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital, the Padera Laboratory uses novel intravital microscopy tools to examine how the lymphatic system drives the progression of cancer through metastatic spread as well as impairment in anti-tumor immune function.

Before enrolling in HST’s Medical Engineering and Medical Physics (MEMP) program, Alisa Morss Clyne was working as a mechanical engineer at General Electric and pursuing a Master’s Degree. In the midst of classes and writing her thesis — on the subject of aircraft engine maintenance — she attended a lecture about the biomechanics of the heart.

“It was fascinating,” she says. “I decided that I wanted to apply my work to helping people.”

The Making of a Serial Inventor-Entrepreneur

In November 2014, Flagship Ventures announced Geoffrey von Maltzahn’s third company since joining the firm, his seventh, if you include the four he co-founded as a graduate student in HST’s Medical Engineering and Medical Physics (MEMP) PhD program. The company, Symbiota, aims to tackle a completely new space for von Maltzahn: agriculture.